Case Study: Paracentral Acute Middle Maculopathy: Structural Recovery with Persistent Scotoma

A 71-year-old male presented with sudden onset of a paracentral scotoma in the left eye while traveling abroad. He described a “blocked-out” region affecting the inferior central visual field that was more noticeable in dim lighting. Medical history was notable for well-controlled type 2 diabetes (A1C ~6.1) and historically low blood pressure (~104/70). One to two weeks prior to symptom onset, the patient reported several days of unilateral temporal headaches.

Initial visual acuity measured 20/20 OD and 20/30 OS. Dilated fundus examination was largely unremarkable, revealing no retinal hemorrhage, edema, or vascular attenuation. A prior posterior vitreous detachment with Weiss ring was noted in the left eye. Visual field testing demonstrated a superior hemifield defect OS, though the patient subjectively reported an inferonasal scotoma.

Figure 1. GCC thickness maps of the right and left eye demonstrated localized parafoveal changes corresponding to the ischemic area in the left eye.

GCC thickness maps of the right and left eye demonstrated localized parafoveal changes corresponding to the ischemic area in the left eye. (Figure 1) Optical Coherence Tomography (OCT) en-face imaging revealed a focal hyperreflective band within the inner retinal layers superior nasal to the fovea, localized to the inner plexiform layer (IPL). (Figure 2) These findings were consistent with Paracentral Acute Middle Maculopathy (PAMM), a form of retinal ischemia affecting the intermediate and deep capillary plexuses. Laboratory testing including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) was within normal limits, reducing the likelihood of giant cell arteritis.  

Figure 2. OCT en-face imaging revealed a focal hyperreflective band within the inner retinal layers superior nasal to the fovea, localized to the inner plexiform layer (IPL). 

Initial cone contrast testing (Figure 3) demonstrated reduced cone contrast sensitivity OS, particularly involving the green cone pathway, suggesting localized retinal dysfunction corresponding to the ischemic region.

Figure 3. Initial cone contrast testing demonstrated reduced cone contrast sensitivity OS, particularly involving the green cone pathway, suggesting localized retinal dysfunction corresponding to the ischemic region. 

The patient was counseled that the scotoma likely represented permanent retinal injury, though central visual acuity was expected to remain stable. Management focused on monitoring retinal structure and emphasizing control of systemic vascular risk factors.

At follow-up several months later, visual acuity had improved to 20/20 OU, though the patient continued to perceive the paracentral scotoma. Repeat OCT imaging demonstrated resolution of the previously observed hyperreflective lesion within the IPL (Figure 4), representing the transition from the acute ischemic phase of PAMM to the chronic stage following retinal infarction.

Figure 4.  Repeat OCT imaging demonstrated resolution of the previously observed hyperreflective lesion within the IPL. 

OCT angiography (OCT-A) revealed persistent vascular abnormalities in the left eye compared with the right, including reduced superficial capillary vessel density and an enlarged foveal avascular zone (FAZ). (Figure 5) FAZ area measured 0.25 mm² OS compared with 0.15 mm² OD, confirming underlying retinal microvascular compromise.  

Figure 5.  OCT Angiography (OCT-A) performed with the Optovue Solix at the follow-up visit revealed persistent vascular abnormalities in the left eye compared with the right, including reduced superficial capillary vessel density and an enlarged foveal avascular zone (FAZ).  

Repeat cone contrast testing (Figure 6) demonstrated substantial functional improvement, with cone contrast scores returning to levels comparable to the fellow eye. This suggests functional recovery within surrounding retinal tissue despite permanent damage to the localized infarct region. Electroretinography confirmed globally intact retinal function, supporting the conclusion that the visual deficit represents localized retinal injury rather than generalized retinal dysfunction.

Figure 6.  Repeat cone contrast testing demonstrated substantial functional improvement OS, with cone contrast scores returning to levels comparable to the right eye. 

Conclusion

This case highlights several important clinical features of PAMM. Fundus examination may appear normal despite significant visual symptoms, emphasizing the importance of OCT imaging in patients presenting with unexplained paracentral vision loss. While structural OCT findings often resolve over time, OCT angiography (OCT-A) may reveal persistent vascular abnormalities corresponding to the original ischemic insult. Functional testing, such as cone contrast sensitivity, may demonstrate recovery in surrounding retinal tissue despite persistent subjective scotoma.

Multimodal imaging—including OCT, OCT-A, and functional testing—provides valuable insight into the structural, vascular, and functional consequences of retinal ischemia.

Key Clinical Takeaways

A few key clinical takeaways from this case include:

• PAMM may present with normal fundus examination findings.
• OCT is essential for identifying inner retinal ischemia.
• OCT-A can reveal persistent microvascular compromise after structural recovery.
• Functional testing may show partial recovery despite permanent scotoma.

OPTOVUE SOLIX BY VISIONIX

• The ONLY OCT with FDA-cleared OCT-A metrics
• FullRange® Retinal 16x6.25mm scan
• FullRange® Anterior Chamber 18x6.25mm scan
• Ultra-fast 120kHz scan speed
• Higher scan density & precision vs. other OCTs/OCT-As
• Integrated fundus camera
• External color & IR imaging
• New optional Topography Module available!
  
  

Walker Shaffer, OD, practices at Eyecare of Lehi in Lehi, Utah, where he provides comprehensive eye care with special interests in glaucoma, macular degeneration, diabetic eye disease, and specialty contact lens fittings. He earned his Bachelor of Vision Science and Doctor of Optometry degrees from the Pacific University College of Optometry in 2024.  

**The information provided is for general informational purposes only. It is not intended to replace and should not be considered a substitute for professional medical advice, diagnosis, or treatment.  The content is not designed to replace the relationship between a patient and their healthcare provider. Any medical decision should be made in consultation with a qualified healthcare professional who can provide information tailored to your individual situation.  Medical procedures, case studies, and practices mentioned in this content may vary depending on regional standards, local regulations, and the discretion of the healthcare provider. The views and experiences expressed are those of the individual user. They may involve off-label use of the medical device, which is not endorsed or approved by the manufacturer. What may be considered appropriate and ethical in one country may differ in another.  The content may include general references to medical practices, medications, or treatments that are widely accepted in certain regions but may not be universally applicable or approved. It is important to consult a healthcare professional in your jurisdiction to ensure that the information is relevant to your specific situation.  The authors, editors, and contributors of this content disclaim any liability for any adverse effects resulting directly or indirectly from the information contained herein. Readers should exercise their own judgment and seek advice from healthcare professionals when necessary.  By accessing and using this content, you acknowledge and accept the terms of this disclaimer.